| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase
|
Silver, Paul J.
|
|
1989
|
63 |
2 |
p. A2-A8
nvt p.
|
artikel
|
| 2 |
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine
|
Hood Jr., William B.
|
|
1989
|
63 |
2 |
p. A46-A53
nvt p.
|
artikel
|
| 3 |
Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow
|
Baim, Donald S.
|
|
1989
|
63 |
2 |
p. A23-A26
nvt p.
|
artikel
|
| 4 |
Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure
|
Packer, Milton
|
|
1989
|
63 |
2 |
p. A41-A45
nvt p.
|
artikel
|
| 5 |
Effects of phosphodiesterase inhibition on skeletal muscle vasculature
|
LeJemtel, Thierry H.
|
|
1989
|
63 |
2 |
p. A27-A30
nvt p.
|
artikel
|
| 6 |
Electrophysiology of phosphodiesterase inhibitors
|
Naccarelli, Gerald V.
|
|
1989
|
63 |
2 |
p. A35-A40
nvt p.
|
artikel
|
| 7 |
Introduction
|
Sonnenblick, Edmund H.
|
|
1989
|
63 |
2 |
p. A1-
1 p.
|
artikel
|
| 8 |
Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure
|
Colucci, Wilson S.
|
|
1989
|
63 |
2 |
p. A17-A22
nvt p.
|
artikel
|
| 9 |
Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesterase peak III inhibitors
|
Evans, Dale B.
|
|
1989
|
63 |
2 |
p. A9-A11
nvt p.
|
artikel
|
| 10 |
Publisher's note
|
|
|
1989
|
63 |
2 |
p. ii-
1 p.
|
artikel
|
| 11 |
Renal and hormonal effects of phosphodiesterase III inhibition in congestive heart failure
|
Cody, Robert J.
|
|
1989
|
63 |
2 |
p. A31-A34
nvt p.
|
artikel
|
| 12 |
The myocardium in congestive heart failure
|
Katz, Arnold M.
|
|
1989
|
63 |
2 |
p. A12-A16
nvt p.
|
artikel
|
Tijdschrift beschrijving